Germline Mutations and Gene Polymorphism Associated With Human Pancreatitis

Endocrinology and Metabolism Clinics of North America

Volumn 35, Issue 2, 2006, Pages 289-302

  Weiss, F Ulrich ^a   Simon, Peter ^a   Mayerle, Julia ^a   Kraft, Matthias ^a   Lerch, Markus M ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DEHYDROGENASE; CATHEPSIN B; CATION; SERINE PROTEINASE INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSIN INHIBITOR; TRYPSINOGEN;

ALCOHOLIC PANCREATITIS; AMINO ACID SUBSTITUTION; CHRONIC PANCREATITIS; CYSTIC FIBROSIS; CYTOKINE RELEASE; DISEASE ASSOCIATION; GENE FUNCTION; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; LIPID METABOLISM; MEDIATOR RELEASE; PANCREAS SECRETION; PANCREATITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW;

CARRIER PROTEINS; CATHEPSIN B; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; PANCREATITIS; POINT MUTATION; POLYMORPHISM, GENETIC; TRYPSINOGEN;

EID: 33646039787     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2006.02.001     Document Type: Review

References (67)

1. Lerch M.M., Saluja A.K., Runzi M., et al. Acute necrotizing pancreatitis in the opossum: earliest morphological changes involve acinar cells. Gastroenterology 103 (1992) 205-213
2. Comfort M.W., and Steinberg A.G. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 21 (1952) 54-63
3. Howes N., Lerch M.M., Greenhalf W., et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2 (2004) 252-261
4. Perrault J. Hereditary pancreatitis: historical perspectives. Med Clin North Am 84 (2000) 519-529
5. Lowenfels A.B., Maisonneuve P., DiMagno E.P., et al. Hereditary pancreatitis and the risk of pancreatic cancer: International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 89 (1997) 442-446
6. Lowenfels A.B., Maisonneuve P., Whitcomb D.C., et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 286 (2001) 169-170
7. Whitcomb D.C., Gorry M.C., Preston R.A., et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14 (1996) 141-145
8. Gaboriaud C., Serre L., Guy-Crotte O., et al. Crystal structure of human trypsin 1: unexpected phosphorylation of Tyr151. J Mol Biol 259 (1996) 995-1010
9. Sahin-Toth M. Human cationic trypsinogen: role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem 275 (2000) 22750-22755
10. LeMarechal C., Chen J.M., Quere I., et al. Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography. BMC Genet 2 (2001) 19
11. Simon P., Weiss F.U., Sahin-Toth M., et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 → Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 277 (2002) 5404-5410
12. Pfutzer R., Myers E., Applebaum-Shapiro S., et al. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis. Gut 50 (2002) 271-272
13. Teich N., Le Marechal C., Kukor Z., et al. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2). Hum Mutat 23 (2004) 22-31
14. Simon P., Weiss F.U., Zimmer K.P., et al. Spontaneous and sporadic trypsinogen mutations in idiopathic pancreatitis. JAMA 288 (2002) 2122
15. Sahin-Toth M. Hereditary pancreatitis-associated mutation asn(21) → ile stabilizes rat trypsinogen in vitro. J Biol Chem 274 (1999) 29699-29704
16. Keim V., Bauer N., Teich N., et al. Clinical characterization of patients with hereditary pancreatitis and mutations in the cationic trypsinogen gene. Am J Med 111 (2001) 622-626
17. Witt H., Luck W., and Becker M. A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology 117 (1999) 7-10
18. Teich N., Ockenga J., Hoffmeister A., et al. Chronic pancreatitis associated with an activation-peptide mutation that facilitates trypsin activation. Gastroenterology 119 (2000) 461-465
19. Ferec C., Raguenes O., Salomon R., et al. Mutations in the cationic trypsinolgen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 36 (1999) 228-232
20. Witt H., Luck W., Hennies H.C., et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25 (2000) 213-216
21. Pfutzer R.H., Barmada M.M., Brunskill A.P., et al. SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 119 (2000) 615-623
22. Threadgold J., Greenhalf W., Ellis I., et al. The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease. Gut 50 (2002) 675-681
23. Drenth J.P., te Morsche R., and Jansen J.B. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis. Gut 50 (2002) 687-692
24. Truninger K., Witt H., Kock J., et al. Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis. Am J Gastroenterol 97 (2002) 1133-1137
25. Weiss F.U., Simon P., Witt H., et al. SPINK1 mutations and phenotypic expression in patients with pancreatitis associated with trypsinogen mutations. J Med Genet 40 (2003) e40
26. Schneider A., Suman A., Rossi L., et al. SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh. Gastroenterology 123 (2002) 1026-1030
27. Chandak G.R., Idris M.M., Reddy D.N., et al. Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis. J Med Genet 39 (2002) 347-351
28. Nathan J.D., Romac J., Peng R.Y., et al. Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice. Gastroenterology 128 (2005) 717-727
29. Kuwata K., Hirota M., Shimizu H., et al. Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J Gastroenterol 37 (2002) 928-934
30. Ohmuraya M., Hirota M., Araki M., et al. Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice. Gastroenterology 129 (2005) 696-705
31. Cohn J.A., Friedman K.J., Noone P.G., et al. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis. N Engl J Med 339 (1998) 653-658
32. Sharer N., Schwarz M., Malone G., et al. Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 339 (1998) 645-652
33. Zeng W., Lee M.G., and Muallem S. Membrane-specific regulation of Cl- channels by purinergic receptors in rat submandibular gland acinar and duct cells. J Biol Chem 272 (1997) 32956-32965
34. DiMagno M.J., Lee S.H., Hao Y., et al. A proinflammatory, antiapoptotic phenotype underlies the susceptibility to acute pancreatitis in cystic fibrosis transmembrane regulator (-/-) mice. Gastroenterology 129 (2005) 665-681
35. Weiss F.U., Simon P., Bogdanova N., et al. Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls. Gut 54 (2005) 1456-1460
36. Creighton J., Lyall R., Wilson D.I., et al. Mutations of the cationic trypsinogen gene in patients with chronic pancreatitis. Lancet 354 (1999) 42-43
37. Monaghan K.G., Jackson C.E., KuKuruga D.L., et al. Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis. Am J Med Genet 94 (2000) 120-124
38. Norton I.D., Apte M.V., Dixson H., et al. Cystic fibrosis genotypes and alcoholic pancreatitis. J Gastroenterol Hepatol 13 (1998) 496-499
39. Haber P.S., Norris M.D., Apte M.V., et al. Alcoholic pancreatitis and polymorphisms of the variable length polythymidine tract in the cystic fibrosis gene. Alcohol Clin Exp Res 23 (1999) 509-512
40. Haber P.S., Apte M.V., Applegate T.L., et al. Metabolism of ethanol by rat pancreatic acinar cells. J Lab Clin Med 132 (1998) 294-302
41. Hata A., Ridinger D.N., Sutherland S., et al. Binding of lipoprotein lipase to heparin: identification of five critical residues in two distinct segments of the amino-terminal domain. J Biol Chem 268 (1993) 8447-8457
42. Brunzell J.D., and Schrott H.G. The interaction of familial and secondary causes of hypertriglyceridemia: role in pancreatitis. Trans Assoc Am Physicians 86 (1973) 245-254
43. Siafakas C.G., Brown M.R., and Miller T.L. Neonatal pancreatitis associated with familial lipoprotein lipase deficiency. J Pediatr Gastroenterol Nutr 29 (1999) 95-98
44. Breckenridge W.C., Little J.A., Steiner G., et al. Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med 298 (1978) 1265-1273
45. Cox D.W., Breckenridge W.C., and Little J.A. Inheritance of apolipoprotein C-II deficiency with hypertriglyceridemia and pancreatitis. N Engl J Med 299 (1978) 1421-1424
46. Levy R.I., and Fredrickson D.S. Familial hyperlipoproteinemia. In: Stanbury J.B., Wyngaarden J.B., and Fredrickson D.S. (Eds). The metabolic basis of inherited disease. 3rd edition (1972), Mac Graw-Hill, New York 545
47. Powell J.J., Fearon K.C., Siriwardena A.K., et al. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1, and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 129 (2001) 633-640
48. Sargen K., Demaine A.G., and Kingsnoth A.N. Cytokine gene polymorphism in acute pancreatitis. JOP 1 (2000) 24-35
49. Smithies A.M., Sargen K., Demaine A.G., et al. Investigations of the interleukin 1 gene cluster and its association with acute pancreatitis. Pancreas 20 (2000) 234-240
50. Teich N., Mossner J., and Keim V. Screening for mutations of the cationic trypsinogen gene: are they of relevance in chronic alcoholic pancreatitis?. Gut 44 (1999) 413-416
51. Beranek H., Teich N., Witt H., et al. Analysis of tumour necrosis factor alpha and interleukin 10 promoter variants in patients with chronic pancreatitis. Eur J Gastroenterol Hepatol 15 (2003) 1223-1227
52. Schneider A., Barmada M.M., Slivka A., et al. Transforming growth factor-beta1, interleukin-10 and interferon-gamma cytokine polymorphisms in patients with hereditary, familial and sporadic chronic pancreatitis. Pancreatology 4 (2004) 490-494
53. Schneider A., Barmada M.M., Slivka A., et al. Analysis of tumor necrosis factor-alpha, transforming growth factor-beta 1, interleukin-10, and interferon-gamma polymorphisms in patients with alcoholic chronic pancreatitis. Alcohol 32 (2004) 19-24
54. Steer M.L., and Meldolesi J. The cell biology of experimental pancreatitis. N Engl J Med 316 (1987) 144-150
55. Figarella C., Miszczuk-Jamska B., and Barrett A. Possible lysosomal activation of pancreatic zymogens: activation of both human trypsinogens by cathepsin B and spontaneous acid activation of human trypsinogen-1. Biol Chem 369 (1988) 293-298
56. Saluja A., Sadamitsu H., Saluja M., et al. Subcellular redistribution of lysosomal enzymes during caerulein-induced pancreatitis. Am J Physiol 253 (1987) G508-G516
57. Watanabe O., Baccino F.M., Steer M.L., et al. Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol 246 (1984) G457-G467
58. Tooze J., Hollinshead M., Hensel G., et al. Regulated secretion of mature cathepsin B from rat exocrine pancreatic cells. Eur J Cell Biol 56 (1991) 187-200
59. Lerch M.M., Saluja A.K., Dawra R., et al. The effect of chloroquine administration on two experimental models of acute pancreatitis. Gastroenterology 104 (1993) 1768-1779
60. Steer M.L., and Saluja A.K. Experimental acute pancreatitis: studies of the early events that lead to cell injury. In: Go V.L.W., DiMagno E.P., Gardner J.D., et al. (Eds). The pancreas: biology, pathobiology, and disease (1993), Raven Press, New York 489-500
61. Leach S.D., Modlin I.M., Scheele G.A., et al. Intracellular activation of digestive zymogens in rat pancreatic acini: stimulation by high does of cholecystokinin. J Clin Invest 87 (1991) 362-366
62. Saluja A.K., Donovan E.A., Yamanaka K., et al. Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B. Gastroenterology 113 (1997) 304-310
63. Gorelick F.S., Modlin I.M., Leach S.D., et al. Intracellular proteolysis of pancreatic zymogens. Yale J Biol Med 65 (1992) 407-420
64. Halangk W., Lerch M.M., Brandt-Nedelev B., et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest 106 (2000) 773-781
65. Szilagyi L., Kenesi E., Katona G., et al. Comparative in vitro studies on native and recombinant human cationic trypsins: cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem 276 (2001) 24574-24580
66. Kukor Z., Mayerle J., Kruger B., et al. Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J Biol Chem 277 (2002) 21389-21396
67. Mahurkar S, Idris MM, Reddy DN, et al. Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis. Gut, in press.